Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial.

Digit Health · 2022 · PMC9638697 · PMID 36353697

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

As mentioned above, PROs constitute highly significant biomarkers for MS, and as such require cost- and time-efficient measurements to enable implementation in clinical routine.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.